+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glucose Biosensors Market Size, Share & Trends Analysis Report by Type (Electrochemical Biosensors, Optical Biosensors), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 130 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 3640157
The global glucose biosensor market size is expected to reach USD 20.1 billion by 2030. The market is expected to expand at a CAGR of 8.2% from 2024 to 2030. Glucose biosensors are an essential part of glucose monitoring systems that aid in monitoring blood glucose concentration in diabetic patients, which, in turn, helps them to manage and control diabetes and avoid any further complications. The International Diabetes Federation stated that in2,021.53 billion people were diagnosed with diabetes, and the number is anticipated to reach 783 million by 2045.

Emerging innovations in glucose monitoring are expanding the market. Glucose biosensors that use different body fluids such as sweat, blood, saliva, and tear and can be calibrated, are being increasingly researched. For instance, in October 2021, Penn State University researchers invented a novel technique that can assess glucose in sweat rather than blood, thus removing the need for a needle prick.

The market's prominent competitors are taking different initiatives such as funding and acquisitions of medium and small-sized businesses, in order to expand their product portfolio and enhance their manufacturing capacity. For instance, in August 2020, Senseonics Holdings entered into a strategic partnership with PHC Holdings Corporation and Ascensia Diabetes Care. This allowed Ascensia to be the exclusive global distribution partner for Senseonics' CGM systems.

Glucose Biosensors Market Report Highlights

  • By type, the electrochemical biosensor segment accounted for the largest revenue share in 2023 owing to its sensitivity, reproducibility, and ease of maintenance
  • The hospital end-use segment held the largest revenue share in 2023, owing to the extensive use of glucose biosensors in hospital settings and an increase in the number of patients visiting hospitals with diabetes.
  • North America accounted for the largest revenue share in 2023. Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period, owing to the improved healthcare facilities and reimbursement policies

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1. Segment Definitions
1.1.1. Type
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End-use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Glucose Biosensors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing incidence of diabetes
3.2.1.2. Rising demand for minimally and small sized glucose monitoring devices
3.2.1.3. Growing patient awareness
3.2.2. Market Restraint Analysis
3.2.2.1. Presence of alternative method
3.3. Glucose Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Glucose Biosensors Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Glucose Biosensors Market: Type Movement Analysis
4.3. Glucose Biosensors Market by Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Electrochemical Biosensor
4.5.1. Electrochemical Biosensor Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Optical Biosensor
4.6.1. Optical Biosensor Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Others
4.7.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Glucose Biosensors Market: End-use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Glucose Biosensors Market: End-use Movement Analysis
5.3. Glucose Biosensors Market by End-use Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospitals
5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Homecare
5.6.1. Homecare Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Diagnostic Centers
5.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Glucose Biosensors Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Glucose Biosensors Market Movement Analysis
6.3. Glucose Biosensors Market: Regional Estimates & Trend Analysis by Technology & End Use
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. North America
6.5.1. North America Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. Europe
6.5.5. Europe Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.6. UK
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement scenario
6.5.6.5. UK Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.7. Germany
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement scenario
6.5.7.5. Germany Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.8. France
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement scenario
6.5.8.5. France Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.9. Italy
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement scenario
6.5.9.5. Italy Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.10. Spain
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Reimbursement scenario
6.5.10.5. Spain Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.11. Denmark
6.5.11.1. Key Country Dynamics
6.5.11.2. Competitive Scenario
6.5.11.3. Regulatory Framework
6.5.11.4. Reimbursement scenario
6.5.11.5. Denmark Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.12. Sweden
6.5.12.1. Key Country Dynamics
6.5.12.2. Competitive Scenario
6.5.12.3. Regulatory Framework
6.5.12.4. Reimbursement scenario
6.5.12.5. Sweden Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.13. Norway
6.5.13.1. Key Country Dynamics
6.5.13.2. Competitive Scenario
6.5.13.3. Regulatory Framework
6.5.13.4. Reimbursement scenario
6.5.13.5. Norway Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Japan Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. China Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. India Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. South Korea Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Australia Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Thailand Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Brazil Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.3. Mexico
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Mexico Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.4. Argentina
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Argentina Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Middle East & Africa
6.8.1. Middle East & Africa Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. South Africa Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Saudi Arabia Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement scenario
6.8.4.5. UAE Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Kuwait Glucose Biosensors Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Abbott Laboratories
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Dexcom
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Ascenia Diabetes Care
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Nova Diabetes Care
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. F. Hoffmann-La Roche AG
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Sanofi
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. GlySens Incorporated
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Trividia Health
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Bayer
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Lifescan
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global glucose biosensors market, by type, 2018-2030 (USD Million)
Table 4 Global glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 5 North America glucose biosensors market, by region, 2018-2030 (USD Million)
Table 6 North America glucose biosensors market, by type, 2018-2030 (USD Million)
Table 7 North America glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 8 U.S. glucose biosensors market, by type, 2018-2030 (USD Million)
Table 9 U.S. glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 10 Canada glucose biosensors market, by type, 2018-2030 (USD Million)
Table 11 Canada glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 12 Europe glucose biosensors market, by country, 2018-2030 (USD Million)
Table 13 Europe glucose biosensors market, by type, 2018-2030 (USD Million)
Table 14 Europe glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 15 UK glucose biosensors market, by type, 2018-2030 (USD Million)
Table 16 UK glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 17 Germany glucose biosensors market, by type, 2018-2030 (USD Million)
Table 18 Germany glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 19 France glucose biosensors market, by type, 2018-2030 (USD Million)
Table 20 France glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 21 Italy glucose biosensors market, by type, 2018-2030 (USD Million)
Table 22 Italy glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 23 Spain glucose biosensors market, by type, 2018-2030 (USD Million)
Table 24 Spain glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 25 Norway glucose biosensors market, by type, 2018-2030 (USD Million)
Table 26 Norway glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 27 Sweden glucose biosensors market, by type, 2018-2030 (USD Million)
Table 28 Sweden glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 29 Denmark glucose biosensors market, by type, 2018-2030 (USD Million)
Table 30 Denmark glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 31 Asia Pacific glucose biosensors market, by country, 2018-2030 (USD Million)
Table 32 Asia Pacific glucose biosensors market, by type, 2018-2030 (USD Million)
Table 33 Asia Pacific glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 34 Japan glucose biosensors market, by type, 2018-2030 (USD Million)
Table 35 Japan glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 36 China glucose biosensors market, by type, 2018-2030 (USD Million)
Table 37 China glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 38 India glucose biosensors market, by type, 2018-2030 (USD Million)
Table 39 India glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 40 Australia glucose biosensors market, by type, 2018-2030 (USD Million)
Table 41 Australia glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 42 South Korea glucose biosensors market, by type, 2018-2030 (USD Million)
Table 43 South Korea glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 44 Thailand glucose biosensors market, by type, 2018-2030 (USD Million)
Table 45 Thailand glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 46 Latin America glucose biosensors market, by country, 2018-2030 (USD Million)
Table 47 Latin America glucose biosensors market, by type, 2018-2030 (USD Million)
Table 48 Latin America glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 49 Brazil glucose biosensors market, by type, 2018-2030 (USD Million)
Table 50 Brazil glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 51 Mexico glucose biosensors market, by type, 2018-2030 (USD Million)
Table 52 Mexico glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 53 Argentina glucose biosensors market, by type, 2018-2030 (USD Million)
Table 54 Argentina glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 55 Middle East & Africa glucose biosensors market, by country, 2018-2030 (USD Million)
Table 56 Middle East & Africa glucose biosensors market, by type, 2018-2030 (USD Million)
Table 57 Middle East & Africa glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 58 South Africa glucose biosensors market, by type, 2018-2030 (USD Million)
Table 59 South Africa glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 60 Saudi Arabia glucose biosensors market, by type, 2018-2030 (USD Million)
Table 61 Saudi Arabia glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 62 UAE glucose biosensors market, by type, 2018-2030 (USD Million)
Table 63 UAE glucose biosensors market, by end-use, 2018-2030 (USD Million)
Table 64 Kuwait glucose biosensors market, by type, 2018-2030 (USD Million)
Table 65 Kuwait glucose biosensors market, by end-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Glucose Biosensors market segmentation
Figure 7 Market driver analysis (Current & future impact)
Figure 8 Market restraint analysis (Current & future impact)
Figure 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Glucose biosensors market, type outlook key takeaways (USD Million)
Figure 12 Glucose biosensors market: type movement analysis (USD Million), 2023 & 2030
Figure 13 Electrochemical biosensor market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 14 Optical biosensor market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 15 Others market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 16 Glucose biosensors market, end-use outlook key takeaways (USD Million)
Figure 17 Glucose biosensors market: end-use movement analysis (USD Million), 2023 & 2030
Figure 18 Hospitals market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 19 Homecare market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Diagnostic centers market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Glucose biosensors market: Regional key takeaways (USD Million)
Figure 22 Glucose biosensors market: regional outlook, 2023 & 2030, USD Million
Figure 23 North America glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 U.S. glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Canada glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Europe glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 UK glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Germany glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 France glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Spain glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Italy glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Sweden glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Norway glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Denmark glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Asia Pacific glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 China glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Japan glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 India glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 South Korea glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Australia glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Thailand glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Latin America glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Brazil glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Mexico glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Argentina glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Middle East and Africa glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 South Africa glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Saudi Arabia glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 UAE glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Kuwait glucose biosensors market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 List of key emerging company’s/technology disruptors/innovators

Companies Mentioned

  • Abbott Laboratories
  • Dexcom
  • Ascenia Diabetes Care
  • Nova Diabetes Care
  • F. Hoffmann-La Roche AG
  • Sanofi
  • GlySens Incorporated
  • Trividia Health
  • Bayer
  • Lifescan

Methodology

Loading
LOADING...

Table Information